Exploring the Role of 177 Lutetium in Advanced Cancer Therapies
Lutetium-177 is revolutionizing advanced cancer therapies, particularly in prostate cancer treatment. This radioactive isotope, used in radioligand therapy, targets cancer cells with precision, minimizing harm to healthy tissues. With FDA approvals and promising clinical trials, Lu-177 is enhancing survival rates and quality of life, marking a significant advancement in cancer care. Explore its transformative potential […]